{Reference Type}: Journal Article
{Title}: Sinonasal Undifferentiated Carcinoma: A 15-Year Single Institution Experience.
{Author}: Workman AD;Brody RM;Kuan EC;Baranov E;Brooks SG;Alonso-Basanta M;Newman JG;Rassekh CH;Chalian AA;Chiu AG;Weinstein GS;Feldman MD;Adappa ND;O'Malley BW;Palmer JN;
{Journal}: J Neurol Surg B Skull Base
{Volume}: 80
{Issue}: 1
{Year}: Feb 2019
{Factor}: 1.407
{DOI}: 10.1055/s-0038-1668537
{Abstract}: Objective  Sinonasal undifferentiated carcinoma (SNUC) is an aggressive neoplasm, with conflicting existing literature regarding prognosis and treatment due to the rarity of disease. Characterization of optimal SNUC management is necessary for improved outcomes. Study Design  Case series with planned data collection and analysis. Setting  Hospital of the University of Pennsylvania and Pennsylvania Hospital. Participants  Patients with pathologically confirmed SNUC treated within a 15-year period were identified, and records were obtained and evaluated for several demographic characteristics. Main Outcomes Measures  Disease-specific survival from diagnosis was the primary endpoint, while disease recurrence was a secondary endpoint of the study. Results  Twenty-seven patients with established SNUC were included in this cohort, with a median age of 55 years. Eighty-five percent of patients were surgically treated, and 85% of patients presented with stage IV disease. Two-year disease-specific survival was 66% and 5-year disease-specific survival was 46%. Ninety-six percent of patients received both chemotherapy and radiation as adjuvant treatment. Nodal disease at presentation and disease recurrence both significantly decreased patient survival ( p  < 0.05). Conclusions  The majority of patients at this institution presented with clinically advanced disease, and most were managed with a multimodal approach of surgical resection, chemotherapy, and radiation. Extent of disease at presentation and progression of disease following treatment are poor prognostic signs and may merit a more aggressive approach, while early detection and treatment may improve survival and decrease patient morbidity.